• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Towards new tools for refined management of patients with advanced hepatocellular carcinoma under systemic therapy: some enthusiasm with a word of caution.

作者信息

Piscaglia Fabio, Cucchetti Alessandro, Dietrich Christoph F, Salvatore Veronica

机构信息

Division of Internal Medicine, Department of Medical and Surgical Sciences - DIMEC, University of Bologna, Bologna, Italy.

出版信息

J Hepatol. 2013 Nov;59(5):924-5. doi: 10.1016/j.jhep.2013.07.028. Epub 2013 Aug 6.

DOI:10.1016/j.jhep.2013.07.028
PMID:23928406
Abstract
摘要

相似文献

1
Towards new tools for refined management of patients with advanced hepatocellular carcinoma under systemic therapy: some enthusiasm with a word of caution.迈向晚期肝细胞癌患者全身治疗精细管理的新工具：虽有热情，但需谨慎。
J Hepatol. 2013 Nov;59(5):924-5. doi: 10.1016/j.jhep.2013.07.028. Epub 2013 Aug 6.
2
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.索拉非尼治疗晚期肝细胞癌患者反应的早期预测：动态对比增强超声的作用。
J Hepatol. 2013 Nov;59(5):1014-21. doi: 10.1016/j.jhep.2013.06.011. Epub 2013 Jun 25.
3
Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome?肝细胞癌的抗肿瘤治疗早期反应——定量对比增强超声能预测结果吗？
Ultraschall Med. 2013 Feb;34(1):38-46. doi: 10.1055/s-0032-1330387. Epub 2012 Dec 20.
4
Education and imaging: Hepatobiliary and pancreatic: Volume-perfusion CT for monitoring therapy for hepatocellular carcinoma.教育与影像学：肝胆胰：用于监测肝细胞癌治疗的容积灌注CT
J Gastroenterol Hepatol. 2013 Mar;28(3):588. doi: 10.1111/jgh.12094.
5
Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: could we stop the treatment? About four cases.根据mRECIST标准经索拉非尼治疗后获得完全影像学缓解的肝细胞癌：我们可以停止治疗吗？约4例病例。
Acta Oncol. 2014 Mar;53(3):420-3. doi: 10.3109/0284186X.2013.795286. Epub 2013 May 29.
6
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study.索拉非尼治疗肝细胞癌的超声造影评价：一项初步研究。
World J Gastroenterol. 2012 Oct 28;18(40):5753-8. doi: 10.3748/wjg.v18.i40.5753.
7
Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US.索拉非尼治疗肝细胞癌：超声造影对治疗反应和主要不良事件的早期检测。
Liver Int. 2013 Apr;33(4):605-15. doi: 10.1111/liv.12098. Epub 2013 Jan 11.
8
Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy.索拉非尼治疗晚期肝细胞癌实现持续完全缓解
J Dig Dis. 2015 Sep;16(9):537-40. doi: 10.1111/1751-2980.12270.
9
Complete radiological response after sorafenib treatment for advanced hepato-cellular carcinoma.索拉非尼治疗晚期肝细胞癌后的完全放射学缓解
Tunis Med. 2015 Jun;93(6):350-2.
10
Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.索拉非尼：晚期肝细胞癌及其他病症的金标准疗法。
Future Oncol. 2015;11(16):2263-6. doi: 10.2217/fon.15.161.

引用本文的文献

1
Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.动态对比增强超声（D-CEUS）用于预测转移性结直肠癌患者贝伐珠单抗疗效的早期评估。
Eur Radiol. 2018 Jul;28(7):2969-2978. doi: 10.1007/s00330-017-5254-5. Epub 2018 Feb 7.
2
Dynamic contrast-enhanced endoscopic ultrasound: A quantification method.动态对比增强内镜超声：一种量化方法。
Endosc Ultrasound. 2017 Jan-Feb;6(1):12-20. doi: 10.4103/2303-9027.193595.
3
Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging.
晚期肝细胞癌抗血管生成疗效评估：生物标志物与功能成像
World J Hepatol. 2015 Sep 18;7(20):2245-63. doi: 10.4254/wjh.v7.i20.2245.